About
Adagio Therapeutics, Inc. is a clinical-stage a biotechnology company developing best-in-class antibodies that can broadly neutralize SARS-CoV-2, SARS-CoV-1 and additional pre-emergent coronaviruses.
- Website
- Headquarters
- Industry
- Employees11-50
- Social
Org chart
View org chartTillman Gerngross
Co-Founder & CEO
Tillman Gerngross
Collapse
Laura Walker
Co-Founder & Chief Scientific Officer
David Hering
COO
Becky Dabora
Chief Technology & Manufacturing Officer
Lynn Connolly
Chief Medical Officer
Ellie Hershberger
Chief Development Officer
Eric Kimble
Chief Commercial Officer
Ed Campanaro
SVP, Clinical Operations
Teams
View all (0)No teams yet!
Jobs
View all (0)No jobs yet!
Wires
View all (0)No wires yet!
By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.